PCSK-9 INHIBITORS: REAL WORLD EFFECTIVENESS (submitted in 2019)
5PSQ-016
TOLVAPTAN ASSOCIATED CREATINE KINASE ELEVATION IN TWO PATIENTS WITH AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE (submitted in 2019)
5PSQ-015
COMPARING THREE CRITERIA FOR ASSESSMENT OF WHAT MEDICINES INCLUDED IN NATIONAL HOSPITAL FORMULARY ARE CLASSIFIED AS POTENTIALLY INAPPROPRIATE MEDICATIONS FOR OLDER PATIENTS (submitted in 2019)
5PSQ-014
RETROSPECTIVE EVALUATION OF RESUSCITATION MEDICATION UTILISATION IN HOSPITALISED ADULT PATIENTS WITH CARDIAC ARREST (submitted in 2019)
5PSQ-013
ANALYSIS OF THE RISK OF QT INTERVAL PROLONGATION IN INSTITUTIONALISED ELDERLY PATIENTS IN A NURSING HOME (submitted in 2019)
5PSQ-012
DRUG INTERACTIONS AND POLYPHARMACY IN A COHORT OF HIV POSITIVE HAEMOPHILIAC PATIENTS (submitted in 2019)
5PSQ-011
COMPLICATIONS OF DRUG CONTAINING PARENTERAL NUTRITION: A COHORT STUDY. (submitted in 2019)
5PSQ-010
BENEFITS PROVIDED BY RECOMBINANT LONG HALF-LIFE COAGULATION FACTORS IN PATIENTS WITH SEVERE HAEMOPHILIA “A” IN PROPHYLAXIS (submitted in 2019)
5PSQ-009
EVALUATION OF DIRECT ORAL ANTICOAGULANT USE IN PATIENTS ADMITTED FOR UPPER GASTROINTESTINAL AND INTRACRANIAL HAEMORRHAGES IN THE EMERGENCY SERVICE (submitted in 2019)
5PSQ-008
RESISTANCE TO SODIUM HEPARIN TREATMENT OR TREATMENT FAILURE TO THE EQUIVALENT ANALOGUE? (submitted in 2019)
5PSQ-007
THE PHARMACEUTICAL GOVERNANCE OF LOW MOLECULAR WEIGHT HEPARINS: APPROPRIATENESS ANALYSIS (submitted in 2019)
5PSQ-006
PARENTERAL NUTRITION IN A NEONATOLOGY INTENSIVE CARE UNIT: DURATION AND COMPLICATIONS (submitted in 2019)
5PSQ-005
ANALYSIS OF THE ADEQUACY OF VITAMIN D PRESCRIPTIONS (submitted in 2019)
5PSQ-004
ADEQUACY OF ANTIEMETIC TREATMENT DURING CHEMOTHERAPY IN A REGIONAL HOSPITAL (submitted in 2019)
5PSQ-003
EFFECTIVENESS OF ANTIEMETIC THERAPY DURING CHEMOTHERAPY IN A REGIONAL HOSPITAL (submitted in 2019)
